Skip to main content
| News

Ariceum Therapeutics establishes subsidiary in Basel

09.02.2023

The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel Area Business & Innovation. Germo Gericke from Novartis was named Chief Medical Officer. He also leads the activities in the Basel Area.

Germo Gericke leads the new subsidiary of Ariceum Therapeutics in Basel (img: Ariceum Therapeutics)

Ariceum Therapeutics has established a subsidiary in Basel. The private biotech company develops radiopharmaceutical products for the diagnosis and systemic targeted radiation therapy of certain hard-to-treat cancers. According to a press release, Germo Gericke from Novartis was named Chief Medical Officer.

Ariceum’s CEO Manfred Rüdiger comments, that the aim of opening the new subsidiary in Basel is to expand the team “to build a global development hub for Ariceum”. He adds that Germo Gericke is bringing a wealth of experience in the area of radiopharmaceutical therapy and that he will lead and develop the team for clinical development and operational processes from the new subsidiary in Basel.

Basel attracts talent from all over Europe

The new Chief Medical Officer Germo Gericke is convinced: “Basel is at the heart of the European Life Sciences industry. It offers a well-connected, business-friendly environment and great networking opportunities thanks to the cluster of sector activity in the area.” He added that the city’s central location attracts talent from all over Europe and beyond. “We offer exciting career development opportunities within a modern office space and the scope to benefit from the great living and working environment that Basel provides, and look forward to tapping into Basel Area’s talent pool.”

Gericke is coming from Advanced Accelerator Applications (AAA), a Novartis company that develops radioligand therapies and imaging radioligands for oncology indications. He was Chief Medical Officer and Head of Research and Development. According to a press release, Gericke has built a global R&D organization for radioligand therapies.

Ariceum Therapeutics with headquarters in Berlin was supported in its settlement in Switzerland by Basel Area Business & Innovation.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Sustainability

Evolva launches new line for manufacturers of personal care products

Evolva, a manufacturer of active ingredients based in Reinach in the canton of Basel-Landschaft, will be presenting its new product...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Record figure for startups in the Basel Area

Basel Area Business & Innovation has supported a record number of 96 company startups in 2022. The number of settlements...

Read More
Noema Pharma raises 103 million Swiss francs from investors
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Noema Pharma raises 103 million Swiss francs from investors

Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....

Read More
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Why CDMO companies choose the Basel Area as their location

Originally, this article was published by the US magazine Outsourced Pharma under the title "Why Location Matters". The article highlights...

Read More
Basel Area Business & Innovation, Innovation, Invest

Basel still the most attractive small city for business in Europe

As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Ariceum Therapeutics establishes subsidiary in Basel

The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...

Read More
1 2 3 61

Do you have a question? We'd like to hear from you.